Hims & Hers Health Inc
NYSE:HIMS

Watchlist Manager
Hims & Hers Health Inc Logo
Hims & Hers Health Inc
NYSE:HIMS
Watchlist
Price: 28.49 USD 1.21% Market Closed
Market Cap: 6.2B USD
Have any thoughts about
Hims & Hers Health Inc?
Write Note

Wall Street
Price Targets

HIMS Price Targets Summary
Hims & Hers Health Inc

Wall Street analysts forecast HIMS stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HIMS is 27.86 USD with a low forecast of 18.18 USD and a high forecast of 44.1 USD.

Lowest
Price Target
18.18 USD
36% Downside
Average
Price Target
27.86 USD
2% Downside
Highest
Price Target
44.1 USD
55% Upside

HIMS Last Price Targets
Hims & Hers Health Inc

The latest public price target was made on Nov 5, 2024 by Ryan MacDonald from Needham , who expects HIMS stock to drop by 2% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Ryan MacDonald
Needham
28 USD
Downside 2%
1 month ago
Nov 5, 2024
Hims and Hers (HIMS) PT Raised to $28 at Needham
StreetInsider
Korinne Wolfmeyer
Piper Sandler
21 USD
Downside 26%
1 month ago
Nov 5, 2024
Hims and Hers (HIMS) PT Raised to $21 at Piper Sandler
StreetInsider
Michael Cherny
Leerink Partners
26 USD
Downside 9%
1 month ago
Oct 29, 2024
Hims and Hers (HIMS) PT Raised to $26 at Leerink Partners
StreetInsider
Michael Cherny
Bank of America Securities
25 USD
Downside 12%
2 months ago
Oct 21, 2024
Hims and Hers (HIMS) PT Raised to $25 at BofA Securities
StreetInsider
Michael Cherny
Bank of America Securities
23 USD
Downside 19%
2 months ago
Oct 14, 2024
Hims and Hers (HIMS) PT Raised to $23 at BofA Securities
StreetInsider
Jailendra Singh
Truist Financial
23 USD
Downside 19%
2 months ago
Oct 14, 2024
Truist Securities Reiterates Hold Rating on Hims and Hers (HIMS)
StreetInsider
Allen Lutz
Bank of America Securities
20 USD
Downside 30%
3 months ago
Sep 13, 2024
Hims & Hers price target lowered to $20 from $24 at BofA
TheFly
Daniel Grosslight
Citigroup
20 USD
Downside 30%
4 months ago
Aug 27, 2024
Citi on Hims and Hers (HIMS) Post Lilly (LLY) News: 'Single-dose Zepbound Vials a Shot Across the Bow for the Compounders'
StreetInsider
Glen Santangelo
Jefferies
18 USD
Downside 37%
4 months ago
Aug 7, 2024
Hims and Hers (HIMS) PT Lowered to $18 at Jefferies
StreetInsider
George Hill
Deutsche Bank
23 USD
Downside 19%
4 months ago
Aug 6, 2024
Hims and Hers (HIMS) PT Raised to $23 at Deutsche Bank
StreetInsider
Maria Ripps
Canaccord Genuity
24 USD
Downside 16%
7 months ago
May 22, 2024
Hims and Hers (HIMS) PT Raised to $24 at Canaccord Genuity
StreetInsider
Korinne Wolfmeyer
Piper Sandler
13 USD
Downside 54%
7 months ago
May 7, 2024
Hims and Hers (HIMS) PT Raised to $13 at Piper Sandler
StreetInsider
Jailendra Singh
Truist Financial
13 USD
Downside 54%
7 months ago
May 7, 2024
Hims & Hers Health's Model 'Proving Effective': 2 Analysts Examine Q1 Earnings
Benzinga
George Hill
Deutsche Bank
16 USD
Downside 44%
7 months ago
May 7, 2024
Hims and Hers (HIMS) PT Raised to $16 at Deutsche Bank
StreetInsider
Glen Santangelo
Jefferies
14 USD
Downside 51%
7 months ago
May 7, 2024
Hims and Hers (HIMS) PT Lowered to $14 at Jefferies
StreetInsider
Glen Santangelo
Jefferies
15 USD
Downside 47%
8 months ago
Apr 16, 2024
Jefferies Downgrades Hims and Hers (HIMS) to Hold
StreetInsider
Maria Ripps
Canaccord Genuity
20 USD
Downside 30%
8 months ago
Apr 10, 2024
Canaccord Genuity Starts Hims and Hers (HIMS) at Buy, 'we see a healthy long-term opportunity'
StreetInsider
Show More Price Targets
Show Less Price Targets
Ryan MacDonald
Needham
Price Target 28 USD
Upside/Downside 2%
View Source
Korinne Wolfmeyer
Piper Sandler
Price Target 21 USD
Upside/Downside 26%
View Source
Michael Cherny
Leerink Partners
Price Target 26 USD
Upside/Downside 9%
View Source
Michael Cherny
Bank of America Securities
Price Target 25 USD
Upside/Downside 12%
View Source
Michael Cherny
Bank of America Securities
Price Target 23 USD
Upside/Downside 19%
View Source
Jailendra Singh
Truist Financial
Price Target 23 USD
Upside/Downside 19%
View Source
Allen Lutz
Bank of America Securities
Price Target 20 USD
Upside/Downside 30%
View Source
Daniel Grosslight
Citigroup
Price Target 20 USD
Upside/Downside 30%
View Source
Glen Santangelo
Jefferies
Price Target 18 USD
Upside/Downside 37%
View Source
George Hill
Deutsche Bank
Price Target 23 USD
Upside/Downside 19%
View Source
Maria Ripps
Canaccord Genuity
Price Target 24 USD
Upside/Downside 16%
View Source
Korinne Wolfmeyer
Piper Sandler
Price Target 13 USD
Upside/Downside 54%
View Source
Jailendra Singh
Truist Financial
Price Target 13 USD
Upside/Downside 54%
View Source
George Hill
Deutsche Bank
Price Target 16 USD
Upside/Downside 44%
View Source
Glen Santangelo
Jefferies
Price Target 14 USD
Upside/Downside 51%
View Source
Glen Santangelo
Jefferies
Price Target 15 USD
Upside/Downside 47%
View Source
Maria Ripps
Canaccord Genuity
Price Target 20 USD
Upside/Downside 30%
View Source
Show More Price Targets
Show Less Price Targets
Hims & Hers Health Inc Competitors:
Price Targets
DVA
DaVita Inc
5% Upside
IDHC
Integrated Diagnostics Holdings PLC
21% Upside
RDNT
RadNet Inc
26% Upside
600763
Topchoice Medical Co Inc
11% Upside
OPTIMAX
Optimax Holdings Bhd
38% Upside
AIDX
Healwell Al Inc
88% Upside
FLRY3
Fleury SA
56% Upside
V3V
Vita 34 AG
57% Upside

Revenue
Forecast

Revenue Estimate
Hims & Hers Health Inc

The compound annual growth rate of Hims & Hers Health Inc's revenue for the next 4 years is 36%.

N/A
Past Growth
36%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Hims & Hers Health Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Hims & Hers Health Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HIMS's stock price target?
Price Target
27.86 USD

According to Wall Street analysts, the average 1-year price target for HIMS is 27.86 USD with a low forecast of 18.18 USD and a high forecast of 44.1 USD.

What is Hims & Hers Health Inc's Revenue forecast?
Projected CAGR
36%

The compound annual growth rate of Hims & Hers Health Inc's revenue for the next 4 years is 36%.

Back to Top